Aaron Osborne, DO
Orthopaedic Trauma · Redding, CANPI 1265460687
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $1,309,803 of the $1,331,301 with a category attached, or 98.4%. Arthrex accounts for 94.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $1,221,831 and has fallen 99.9% since, to $698 in 2024. Among orthopaedic trauma clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 57 payments — averaging $23,356 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$1.3M
- Advanced Orthopaedic Solutions, Inc.$68K
- Steelhead Surgical Inc$1K
- Shoulder Innovations, Inc.$698
- Johnson & Johnson$414
- Smith+Nephew$231
- plus $153 from 3 others
What the payments were for
- Royalty or licence$1,309,80398%
- Consulting fees$13,3981%
- Travel & lodging$4,4220%
- Food & beverage$2,4790%
- Education$1,2000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 24 | $1,260,725 |
| Advanced Orthopaedic Solutions, Inc. | 19 | $67,794 |
| Steelhead Surgical Inc | 2 | $1,286 |
| Shoulder Innovations, Inc. | 1 | $698 |
| Johnson & Johnson | 5 | $414 |
| Smith+Nephew | 2 | $231 |
| Stryker | 1 | $107 |
| Pacira Therapeutics, Inc. | 2 | $25 |
| Merck | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AOS RETROGRADE FEMORAL NAIL 10MM X 36CM$37,463
- AOS RETROGRADE FEMORAL NAIL 10MM X 38CM$37,463
- AOS PRODUCTS$34,249
- MAGELLAN FEMORAL NAIL SYSTEM$27,163
- Trochanteric Nail$6,276
- InSet System$698
- REAL INTELLIGENCE$150
- DISTAL EXTREMITIES IMPLANTS TRAUMA DISTAL RADIUS$118
- DYNACORD$111
- DISTAL EXTREMITIES IMPLANTS TRAUMA SYNDESMOSIS TIGHTROPES$103
- NA$101
How this compares
$1,331,301 in reported general payments places this provider in the 95th percentile of 106 orthopaedic trauma providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 23 | $225 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic trauma in Redding
- Michael GardnerStanford$2.9M
- Robert Tonksla Jolla$1.3M
- John ScolaroOrange$1M
- David LowenbergSan Francisco$788K
- Eric LindvallClovis$609K
- Christopher LeeLos Angeles$475K
- Joshua GaryLos Angeles$466K
- Christopher HoshinoTorrance$356K
- Julius BishopStanford$349K
- Mark LeeSacramento$287K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.